iCo Therapeutics (iCo Therapeutics) Total Assets : $1.74 Mil (As of Mar. 2021)

View and export this data going back to 2009. Start your Free Trial

What is iCo Therapeutics Total Assets?

iCo Therapeutics's Total Assets for the quarter that ended in Mar. 2021 was $1.74 Mil.

During the past 12 months, iCo Therapeutics's average Total Assets Growth Rate was -88.50% per year. During the past 3 years, the average Total Assets Growth Rate was 24.70% per year. During the past 5 years, the average Total Assets Growth Rate was 35.70% per year. During the past 10 years, the average Total Assets Growth Rate was -16.80% per year.

During the past 13 years, iCo Therapeutics's highest 3-Year average Total Assets Growth Rate was 525.20%. The lowest was -64.50%. And the median was 15.00%.

Total Assets is connected with ROA %. iCo Therapeutics's annualized ROA % for the quarter that ended in Mar. 2021 was -226.99%. Total Assets is also linked to Revenue through Asset Turnover. iCo Therapeutics's Asset Turnover for the quarter that ended in Mar. 2021 was 0.00.

iCo Therapeutics Total Assets Historical Data

The historical data trend for iCo Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iCo Therapeutics Total Assets Chart

iCo Therapeutics Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Total Assets

Get a 7-Day Free Trial

1.84

1.08

0.13

1.12

0.43

iCo Therapeutics Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Total Assets	Get a 7-Day Free Trial															0.85	0.63	0.48	0.43	1.74

iCo Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

iCo Therapeutics's Total Assets for the fiscal year that ended in Dec. 2020 is calculated as

Total Assets	=	Total Equity (A: Dec. 2020 )	+	Total Liabilities (A: Dec. 2020 )
	=	-0.586	+	1.013
	=	0.43

iCo Therapeutics's Total Assets for the quarter that ended in Mar. 2021 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2021 )	+	Total Liabilities (Q: Mar. 2021 )
	=	0.21	+	1.528
	=	1.74

iCo Therapeutics (GREY:ICOTF) Total Assets Explanation

Total Assets is connected with ROA %.

iCo Therapeutics's annualized ROA % for the quarter that ended in Mar. 2021 is

ROA %	=	Net Income (Q: Mar. 2021 )	/	( (Total Assets (Q: Dec. 2020 )	+	Total Assets (Q: Mar. 2021 ))	/ count )
	=	-2.456	/	( (0.426	+	1.738)	/ 2 )
	=	-2.456	/	1.082
	=	-226.99 %

Note: The Net Income data used here is four times the quarterly (Mar. 2021) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

iCo Therapeutics's Asset Turnover for the quarter that ended in Mar. 2021 is

	Asset Turnover
=	Revenue (Q: Mar. 2021 )	/	( (Total Assets (Q: Dec. 2020 )	+	Total Assets (Q: Mar. 2021 ))	/ count )
=	0	/	( (0.426	+	1.738)	/ 2 )
=	0	/	1.082
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

iCo Therapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of iCo Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

iCo Therapeutics (iCo Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » iCo Therapeutics Inc (GREY:ICOTF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

777 Hornby Street, 6th Floor, Vancouver, BC, CAN, V6Z 1S4

Website

http://www.icotherapeutics.com

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between the cells of the immune system. Geographically, it operates in Canada and Australia.

iCo Therapeutics (iCo Therapeutics) Headlines

No Headlines